Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B screening in pregnancy: practical aspects.

V A Moyer1

  • 1Department of Pediatrics, UT Health Science Center, Houston 77030.

Texas Medicine
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children.

The Cochrane database of systematic reviews·2003
Same author

Is the practice of paediatric inpatient medicine evidence-based?

Journal of paediatrics and child health·2002
Same author

Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials.

Archives of disease in childhood·2002
Same author

Evidence syntheses in child health.

Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association·2002
Same author

Evidence based paediatrics: Evidence based management of seizures associated with fever.

BMJ (Clinical research ed.)·2001
Same author

Evidence based well child care.

BMJ (Clinical research ed.)·2001
Same journal

Commentary: This Is Not a Drill.

Texas medicine·2021
Same journal

Healthy Determination: Texas Physicians are Finding Better Ways to Address Their Patients' Social Determinants of Health.

Texas medicine·2021
Same journal

Going Local: Accountable Health Organizations Could Help Combat Social Disparities at the Local Level.

Texas medicine·2021
Same journal

Data Driven: Medicaid's Inspector General Focuses on Fraud Prevention, Not Just Prosecution.

Texas medicine·2021
Same journal

Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).

Texas medicine·2021
Same journal

Obstacles to Clear.

Texas medicine·2021
See all related articles

Universal screening for Hepatitis B in pregnant women is clinically effective and cost-effective. This approach prevents debilitating liver disease acquired at birth from chronic carrier mothers, aligning with CDC recommendations.

Area of Science:

  • Hepatology
  • Public Health
  • Preventive Medicine

Background:

  • Hepatitis B infection can be transmitted from mother to child at birth.
  • Vertical transmission can lead to chronic liver disease later in life.
  • Early screening and preventive measures are crucial for mitigating Hepatitis B's impact.

Purpose of the Study:

  • To evaluate the clinical effectiveness and cost-effectiveness of universal Hepatitis B screening in pregnant women.
  • To describe the practical implementation of a screening program for a high-risk population.
  • To identify excess costs and challenges associated with screening program implementation.

Main Methods:

  • Review of clinical effectiveness data for screening and preventive measures.
  • Cost-effectiveness analysis using estimated costs and patient compliance assumptions.

Related Experiment Videos

  • Description of a single screening program's practical aspects and implementation challenges.

    • Main Results:

    • Screening of pregnant women and subsequent preventive measures are clinically effective.
    • These interventions are considered at least marginally cost-effective.
    • The Centers for Disease Control and Prevention recommends universal screening for pregnant women.

    Conclusions:

    • Universal screening for Hepatitis B in pregnant women is a recommended public health strategy.
    • Effective implementation requires addressing practical challenges and associated costs.
    • Preventing perinatal Hepatitis B transmission is vital for reducing long-term liver disease burden.